Samuel Nguku Gitau

Samuel Nguku Gitau

Auto-generated profile, based on publicly available information

Samuel Nguku Gitau


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in Circulation Research
Verified
Journal Article
Closed access
JHJonathan A. Hudson
Jonathan A. Hudson
RFRashida Abbas Ferrand
Rashida Abbas Ferrand
SGSamuel N. Gitau
Samuel N. Gitau
Marianne MureithiMarianne Mureithi
Marianne Mureithi
PMPasquale Maffia
Pasquale Maffia
ASAnoop S.V. Shah
Anoop S.V. Shah
Cardiac abnormalities were identified early in the epidemic of AIDS, predating the isolation and characterization of the etiologic agent, HIV. Several decades later, the causation and pathogenesis of cardiovascular disease (CVD) linked to HIV infection continue to be the focus of intense speculation. Before the widespread use of antiretroviral therapy, HIV-associated CVD was primarily characterized by HIV-associated cardiomyopathy linked to profound immunodeficiency. With increasing antiretroviral therapy use, viral load suppression, and establishment of immune competency, the effects of HIV on the cardiovascular system are more subtle. Yet, people living with HIV still face an increased incidence of cardiovascular pathology. Advances in cardiac imaging modalities and immunology have deepened our understanding of the pathogenesis of HIV-associated CVD. This review provides an overview of the pathogenesis of HIV-associated CVD integrating data from imaging and immunologic studies with particular relevance to the HIV population originating from high-endemic regions, such as sub-Saharan Africa. The review highlights key evidence gaps in the field and suggests future directions for research to better understand the complex HIV-CVD interactions.

1 July 2024
Verified
Conference Paper
Open access
HZHubert Dariusz Zając
Hubert Dariusz Zając
JRJorge Ribeiro
Jorge Ribeiro
SISilvia Ingala
Silvia Ingala
SGSimona Gentile
Simona Gentile
RWRuth Wanjohi
Ruth Wanjohi
TATariq Osman Andersen
Tariq Osman Andersen
Artificial Intelligence (AI) repeatedly match or outperform radiologists in lab experiments. However, real-world implementations of radiological AI-based systems are found to provide little to no clinical value. This paper explores how to design AI for clinical usefulness in different contexts. We conducted 19 design sessions and design interventions with 13 radiologists from 7 clinical sites in Denmark and Kenya, based on three iterations of a functional AI-based prototype. Ten sociotechnical dependencies were identified as crucial for the design of AI in radiology. We conceptualised four technical dimensions that must be configured to the intended clinical context of use: AI functionality, AI medical focus, AI decision threshold, and AI Explainability. We present four design recommendations on how to address dependencies pertaining to the medical knowledge, clinic type, user expertise level, patient context, and user situation that condition the configuration of these technical dimensions.

20 April 2025 in ACM Transactions on Computer-Human Interaction
Verified
Journal Article
Open access
HZHubert D. Zając
Hubert D. Zając
TATariq Osman Andersen
Tariq Osman Andersen
EKElijah Kwasa
Elijah Kwasa
RWRuth Wanjohi
Ruth Wanjohi
MOMary K. Onyinkwa
Mary K. Onyinkwa
YCYunan Chen
Yunan Chen
Despite recent advancements, real-world use of Artificial Intelligence (AI) in radiology remains low, often due to the mismatch between AI offerings and the situated challenges faced by healthcare professionals. To bridge this gap, we conducted a field study at nine medical sites in Denmark and Kenya with two goals: (1) to understand the challenges faced by radiologists during chest X-ray practice and (2) to envision alternative AI futures that align with collaborative clinical work. This study uniquely grounds the AI design insights in the comprehensive characterisation of diagnostic work across multiple geographical and institutional contexts. Building on ideas articulated by interviewed radiologists (N = 18), we conceptualised five visions that transcend the traditional notions of AI support. These visions emphasise that the clinical usefulness of AI-based systems depends on their configurability and flexibility across three dimensions: type of clinical site, expertise of medical professionals, and situational and patient contexts. Addressing these dependencies requires expanding the clinical AI design space by envisioning futures rooted in the realities of practice rather than solely following the trajectory of AI development.

1 January 2020 in BJR|case reports
Verified
Journal Article
Open access
SGSamuel Nguku Gitau
Samuel Nguku Gitau
ANAllan Njau
Allan Njau
SMSitna Mwanzi
Sitna Mwanzi
Breast cancer is the most common cancer in women globally as well as in Kenya. The most common sites of metastases reported include the bones, liver and lung. Metastasis to the urinary bladder is relatively uncommon with only a few case reports in literature. It can therefore be easily overlooked as a cause of hematuria in these patients. We describe a rare case of a patient with breast cancer who presented with urinary bladder metastasis as a late complication of her illness.

9 March 2018 in Clinical and Translational Imaging
Verified
Journal Article
Closed access
PDF file
ENEdward C. Nganga
Edward C. Nganga
SGSamuel Gitau
Samuel Gitau
KMKhalid Makhdomi
Khalid Makhdomi

14 September 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
SAShirjel R. Alam
Shirjel R. Alam
SVSudhir Vinayak
Sudhir Vinayak
ASAdeel Shah
Adeel Shah
GDGemina Doolub
Gemina Doolub
RKRedemptar Kimeu
Redemptar Kimeu
ASAnoop S. V. Shah
Anoop S. V. Shah
Background: Acute COVID‐19–related myocardial, pulmonary, and vascular pathology and how these relate to each other remain unclear. To our knowledge, no studies have used complementary imaging techniques, including molecular imaging, to elucidate this. We used multimodality imaging and biochemical sampling in vivo to identify the pathobiology of acute COVID‐19. Specifically, we investigated the presence of myocardial inflammation and its association with coronary artery disease, systemic vasculitis, and pneumonitis. Methods and Results: Consecutive patients presenting with acute COVID‐19 were prospectively recruited during hospital admission in this cross‐sectional study. Imaging involved computed tomography coronary angiography (identified coronary disease), cardiac 2‐deoxy‐2‐[fluorine‐18]fluoro‐D‐glucose positron emission tomography/computed tomography (identified vascular, cardiac, and pulmonary inflammatory cell infiltration), and cardiac magnetic resonance (identified myocardial disease) alongside biomarker sampling. Of 33 patients (median age 51 years, 94% men), 24 (73%) had respiratory symptoms, with the remainder having nonspecific viral symptoms. A total of 9 patients (35%, n=9/25) had cardiac magnetic resonance–defined myocarditis. Of these patients, 53% (n=5/8) had myocardial inflammatory cell infiltration. A total of 2 patients (5%) had elevated troponin levels. Cardiac troponin concentrations were not significantly higher in patients with and without myocarditis (8.4 ng/L [interquartile range, IQR: 4.0–55.3] versus 3.5 ng/L [IQR: 2.5–5.5]; P =0.07) or myocardial cell infiltration (4.4 ng/L [IQR: 3.4–8.3] versus 3.5 ng/L [IQR: 2.8–7.2]; P =0.89). No patients had obstructive coronary artery disease or vasculitis. Pulmonary inflammation and consolidation (percentage of total lung volume) was 17% (IQR: 5%–31%) and 11% (IQR: 7%–18%), respectively. Neither were associated with the presence of myocarditis. Conclusions: Myocarditis was present in a third patients with acute COVID‐19, and the majority had inflammatory cell infiltration. Pneumonitis was ubiquitous, but this inflammation was not associated with myocarditis. The mechanism of cardiac pathology is nonischemic and not attributable to a vasculitic process. Registration: URL: https://www.isrctn.com ; Unique identifier: ISRCTN12154994.